Antibiotic-modified gut microflora can also influence neuroinflammation and amyloidosis in an AD mouse model [212], while healthy gut microbiota can reduce Aβ aggregates and tau pathology in the brains of AD mice [213]. Here, MAPT is linked to Alzheimer disease.